Matthew D. Galsky

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  

Matthew D. Galsky
Jan 16, 2025, 22:31 | Blog
Andrea Necchi: All you need to know about TAR-200
Andrea Necchi, Associate Editor of the Journal of Clinical Oncology, shared on LinkedIn: "All you…
Jan 15, 2025, 13:07 | Blog
Yan Leyfman: Using routine blood tests to predict immunotherapy response across multiple cancers
Yan Leyfman, Co-founder and executive director of MedNews Week, shared on LinkedIn: "Honored to contribute…
Jan 10, 2025, 18:33 | Opinion
5 Articles in Immunotherapy suggested by Wafik El-Deiry
Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at…
Jan 7, 2025, 11:18 | Blog
Hung Trinh: Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data
Hung Trinh, Senior Director of Business Development at OBiO Tech, shared on LinkedIn: "Nature Medicine:…
Dec 25, 2024, 17:26 | Science
Adjuvant nivolumab in Muscle-Invasive Urothelial Carcinoma
Amol Akhade, Senior consultant medical oncologist and hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals,…
Nov 30, 2024, 23:26 | Blog
Enrique Grande: SITC Guideline on Immunotherapy for Urothelial Cancer
Enrique Grande, the Head of Oncology at MD Anderson Cancer Center Madrid, shared a post…
Nov 15, 2024, 12:02 | Insight
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Bladder Cancer
Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X: "Perioperative Durvalumab with…
Oct 28, 2024, 08:58 | Insight
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Sep 30, 2024, 16:54 | Insight
Tom Powles: 1st perioperative immune therapy study to show an OS in bladder cancer
Tom Powles shared an article on X: "Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder…
Sep 24, 2024, 12:30 | Societies
11 ESMO24 presentations published on NEJM
At the 2024 ESMO Congress, 11 articles were presented that were published in NEJM, highlighting…
Sep 19, 2024, 15:48 | Insight
Tom Powles: The 1st perioperative immune therapy study to show an OS in bladder cancer
Tom Powles shared a post on X: “Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder…
All: 11 Posts: 1 - 100
Special Coverage